Jul 24, 2017 12:01 pm UTC| Business
Statistical significance not achieved in primary or secondary efficacy endpointsClinically meaningful efficacy trends observed in primary and secondary endpoints in pre-specified diffuse cutaneous scleroderma subgroupNo...
Spark Energy, Inc. to Present Second Quarter 2017 Financial Results on Friday, August 4, 2017
Jul 24, 2017 12:01 pm UTC| Business
HOUSTON, July 24, 2017 -- Spark Energy, Inc. (NASDAQ:SPKE), a Delaware corporation (“Spark” or the “Company”), announced today that it plans to present its Second Quarter 2017 financial results in a conference call and...
Motorcar Parts of America Acquires Leading Automotive Component Testing Company
Jul 24, 2017 12:01 pm UTC| Business
LOS ANGELES, Calif., July 24, 2017 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today announced it has acquired DV Electronics, an Ontario, Canada-based company in a stock purchase transaction. Terms were not...
D&V Electronics Ltd. Acquired by Motorcar Parts of America
Jul 24, 2017 12:01 pm UTC| Business
WOODBRIDGE, Ontario, July 24, 2017 -- DV Electronics today announced it has accepted an offer to be acquired by Motorcar Parts of America (Nasdaq:MPAA) and will operate as an independent testing company. Terms of the...
ASML reports transactions under its current share buyback program
Jul 24, 2017 12:01 pm UTC| Business
VELDHOVEN, the Netherlands - ASML Holding N.V. (ASML) reports the following transactions, conducted under ASML's current share buyback program. Date Total repurchased shares Weighted average price Total repurchased...
ITW Reports Second-Quarter 2017 Results
Jul 24, 2017 12:01 pm UTC| Business
Second-quarter highlights: GAAP EPS of $1.69, an increase of 16%Total revenue of $3.6 billion, an increase of 4.9%; organic growth of 2.6%Operating margin of 24.3%, an increase of 120 bps and an all-time record for the...
Achaogen Announces New Employment Inducement Grants
Jul 24, 2017 12:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., July 24, 2017 -- Achaogen, Inc. (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections,...